• Adipose-Neural Axis Drives Cardiac Arrhythmias via Leptin-NP

  2026-05-05

  Fan et al. (2024) reveal that epicardial adipose tissue (EAT) contributes to cardiac arrhythmogenesis by activating a leptin–neuropeptide Y (NPY) neural circuit, which modulates cardiomyocyte excitability. Their stem cell-based coculture model identifies the NPY/Y1 receptor axis as a potential intervention target, highlighting new therapeutic directions for atrial fibrillation and related arrhythmias.

• Triptolide (PG490): Precision Workflows in Cancer & Immunolo

  2026-05-04

  Triptolide (PG490) empowers researchers with nanomolar potency and multifaceted suppression of tumor cell proliferation, immune signaling, and inflammatory mediators. This article translates cutting-edge mechanistic insights and the latest workflow guidance into actionable protocols, troubleshooting strategies, and advanced applications for oncology and immunology labs.

• Cdk5 Inhibition Mitigates Neuronal Ferroptosis via AMPK and

  2026-05-04

  This study reveals that downregulating Cdk5 in ischemic stroke models reduces hippocampal neuron ferroptosis by modulating AMPK signaling and microglial polarization. The findings provide mechanistic insight into the intersection of neuroinflammation, iron metabolism, and cell death, suggesting new avenues for therapeutic intervention.

• GS-441524 Prodrug: Conversion Pathways, Solubility, and Phar

  2026-05-03

  Explore the mechanisms and advanced pharmacokinetic insights of GS-441524, a leading nucleoside analog in antiviral research. This article goes beyond established protocols, revealing conversion pathways and solubility challenges that inform next-generation assay and drug development.

• BIBP 3226 trifluoroacetate: Reliable NPY/NPFF Antagonist for

  2026-05-02

  This article addresses real laboratory challenges in cell viability, proliferation, and neuropeptide signaling assays by demonstrating how BIBP 3226 trifluoroacetate (SKU B7155) offers reproducible, data-backed solutions. Through scenario-driven Q&A, we explore its unique advantages for NPY/NPFF system research and guide biomedical scientists in optimizing experimental reliability and workflow efficiency.

• AP20187: Chemical Inducer of Dimerization for Precision Gene

  2026-05-01

  AP20187 empowers researchers to achieve tunable, reversible activation of signaling pathways through precise protein dimerization, making it indispensable for conditional gene therapy and metabolic research. Its high purity, solubility, and robust validation in both in vitro and in vivo models elevate experimental reliability and translational impact.

• Cyclo (-RGDfC): Advancing Integrin-Driven Tumor Targeting

  2026-05-01

  This thought-leadership piece explores Cyclo (-RGDfC), a cyclic RGD peptide, as a precision tool for translational oncology and angiogenesis research. By blending mechanistic insights with actionable experimental guidance, it contextualizes the peptide’s value in the light of recent advances in digital hydrogel platforms and high-throughput workflows, while offering a strategic perspective for researchers looking to maximize the translational impact of integrin αvβ3 targeting.

• Scenario Solutions: Prestained Protein Marker (Triple color,

  2026-04-30

  This article offers evidence-based, scenario-driven guidance for using the Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) (SKU F4005) in cell biology workflows. Readers will learn how this tri-color ladder from APExBIO delivers reproducible SDS-PAGE molecular weight standards, robust Western blot protein size verification, and compatibility with advanced protocols—empowering reliable, publication-ready data.

• Toremifene Citrate: Oral SERM Benchmarks in Breast Cancer Re

  2026-04-30

  Toremifene Citrate is a clinically validated oral selective estrogen receptor modulator used in breast cancer and endocrinology research. Its dual antagonistic and tissue-selective agonistic effects on ERα and ERβ make it a gold standard for dissecting estrogen receptor signaling pathways. APExBIO’s Toremifene Citrate (SKU B1513) offers reproducible, high-purity material for advanced experimental workflows.

• Phenothiazines Inhibit Melanoma Cell Viability and Motility

  2026-04-29

  This study demonstrates that perphenazine and prochlorperazine, two phenothiazine derivatives, selectively reduce cell viability and motility in both melanotic and amelanotic human melanoma cell lines. The findings highlight mechanistic links to MITF and tyrosinase regulation, suggesting these agents may restore sensitivity in resistant melanoma subtypes, with implications for developing targeted antimelanoma strategies.

• Genetically Encoded NADH/NAD+ Redox Biosensor in E. coli

  2026-04-29

  Liu et al. engineered a ratiometric, genetically encoded biosensor for real-time, high-throughput measurement of NADH/NAD+ redox state in bacteria. The system leverages a Rex-regulated promoter, enabling precise quantification and facilitating genome-wide redox screening to advance metabolic engineering and systems biology.

• LG 101506 (RXR modulator): Reliable Solutions for RXR Resear

  2026-04-28

  This article guides biomedical researchers through common experimental challenges in RXR signaling pathway research, emphasizing how LG 101506 (RXR modulator), SKU B7414, delivers reproducible, high-purity results. Integrating scenario-driven Q&A, the discussion highlights practical workflow advantages and literature-backed insights for cell viability, proliferation, and immuno-oncology assays.

• EdU Imaging Kits: Precision Cell Proliferation Assays Made E

  2026-04-28

  EdU Imaging Kits (HF488) from APExBIO redefine cell proliferation analysis with rapid, click chemistry-based DNA synthesis detection. Optimized for both fluorescence microscopy and flow cytometry, these kits outperform legacy assays, enabling reproducible, high-sensitivity S-phase measurements for translational and precision oncology research.

• Super-Enhancer RNA Drives NPC Metastasis via NPM1/c-Myc/NDRG

  2026-04-27

  This study demonstrates that carcinogen-induced super-enhancer RNA (seRNA-NPCm) promotes nasopharyngeal carcinoma (NPC) metastasis by modulating the NPM1/c-Myc/NDRG1 axis. The findings provide mechanistic insight into how environmental nitrosamines drive aggressive NPC phenotypes and highlight regulatory RNA as a potential biomarker and therapeutic target.

• Antidepressant Properties of Rotigotine in Preclinical Model

  2026-04-27

  This reference study demonstrates that Rotigotine, a dopamine D2/D3 receptor agonist, exhibits significant antidepressant-like effects in validated rodent models of depression. The work highlights dose-dependent behavioral improvements, providing a mechanistic bridge between dopaminergic signaling and mood regulation, and opens new avenues for research at the intersection of Parkinson's disease and affective disorders.

16163 records 1/1078 page Next 12345 下5页 Last page